Grantham, Mayo, Van Otterloo & Co (GMO)
AMTX icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Aemetis AMTX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio AMTX Stock Details AMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.35M Sell
1,050,017
-4,606
-0.4% -$8.38K 0.01% 378
2025
Q4 		$1.47M Buy
1,054,623
+43,211
+4% +$86.9K ﹤0.01% 442
2025
Q3 		$2.28M Sell
1,011,412
-652,100
-39% -$1.73M 0.01% 365
2025
Q2 		$4.13M Sell
1,663,512
-64,900
-4% -$110K 0.01% 316
2025
Q1 		$3.01M Sell
1,728,412
-62,027
-3% -$133K 0.01% 349
2024
Q4 		$4.82M Sell
1,790,439
-22,900
-1% -$72K 0.02% 308
2024
Q3 		$4.17M Sell
1,813,339
-78,045
-4% -$219K 0.01% 336
2024
Q2 		$5.69M Buy
1,891,384
+7,300
+0.4% +$27.8K 0.02% 307
2024
Q1 		$11.3M Buy
1,884,084
+68,820
+4% +$261K 0.04% 250
2023
Q4 		$9.51M Sell
1,815,264
-157,000
-8% -$742K 0.04% 242
2023
Q3 		$8.18M Sell
1,972,264
-128,979
-6% -$789K 0.04% 276
2023
Q2 		$15.4M Sell
2,101,243
-35,300
-2% -$134K 0.07% 209
2023
Q1 		$4.96M Buy
2,136,543
+93,100
+5% +$347K 0.03% 322
2022
Q4 		$8.09M Sell
2,043,443
-2,300
-0.1% -$13.1K 0.04% 269
2022
Q3 		$12.5M Sell
2,045,743
-377,345
-16% -$2.87M 0.07% 222
2022
Q2 		$11.9M Buy
2,423,088
+538,104
+29% +$4.7M 0.06% 241
2022
Q1 		$23.9M Buy
1,884,984
+716,514
+61% +$7.9M 0.12% 168
2021
Q4 		$14.4M Sell
1,168,470
-750,043
-39% -$13.2M 0.07% 206
2021
Q3 		$35.1M Buy
1,918,513
+507,019
+36% +$5.6M 0.17% 93
2021
Q2 		$15.8M Buy
+1,411,494
New +$22.2M 0.08% 190

Other funds holding AMTX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s AMTX Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Aemetis (AMTX) stake by 0.44% in Q1 2026, selling an estimated $8.38K and leaving 1,050,017 shares worth $3.35M. The position accounts for 0.01% of the portfolio, ranked #378.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AMTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $35.1M in Q3 2021. 78 funds tracked by Wall St. Rank hold AMTX as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 1,050,017 shares of Aemetis worth $3.35M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,606 Aemetis shares in Q1 2026, an estimated $8.38K.
  • Aemetis made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #378 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Aemetis in Q2 2021 and has held it in 20 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Aemetis position peaked at $35.1M in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Aemetis as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.